Human papillomavirus E7 induces p63 expression to modulate DNA damage response.
Name:
s41419-017-0149-6.pdf
Size:
1.421Mb
Format:
PDF
Description:
Open access full text article
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester Cancer Research Centre, Wilmslow Road, Manchester, M20 4QL, UKIssue Date
2018-01-26
Metadata
Show full item recordAbstract
Cervical cancer is the third most common malignancy diagnosed in women worldwide. The major aetiological factor underlying the malignant transformation of cervical cells is the persistent infection with high-risk human papillomaviruses (HR-HPV), with more than 99% of cases expressing viral sequences. Here, we report a previously unknown mechanism driven by high-risk human papillomavirus E7 protein to modulate response to DNA damage in cervical cancer cells. Our data shows that HR-HPV E7 oncoprotein induces the transcription of the p53-family member p63, which modulates DNA damage response pathways, to facilitate repair of DNA damage. Based on our findings, we proposed a model, where HR-HPV could interfere with the sensitivity of transformed cells to radiation therapy by modulating DNA damage repair efficiency. Importantly, we have shown for the first time a critical role for p63 in response to DNA damage in cervical cancer cells.Citation
Human papillomavirus E7 induces p63 expression to modulate DNA damage response. 2018, 9 (2):127 Cell Death DisJournal
Cell Death & DiseaseDOI
10.1038/s41419-017-0149-6PubMed ID
29374145Type
ArticleLanguage
enISSN
2041-4889ae974a485f413a2113503eed53cd6c53
10.1038/s41419-017-0149-6
Scopus Count
Collections
Related articles
- Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
- Authors: Sitz J, Blanchet SA, Gameiro SF, Biquand E, Morgan TM, Galloy M, Dessapt J, Lavoie EG, Blondeau A, Smith BC, Mymryk JS, Moody CA, Fradet-Turcotte A
- Issue date: 2019 Sep 24
- MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
- Authors: Morgan EL, Patterson MR, Ryder EL, Lee SY, Wasson CW, Harper KL, Li Y, Griffin S, Blair GE, Whitehouse A, Macdonald A
- Issue date: 2020 Jun
- Human Papillomavirus E7 Oncoprotein Promotes Proliferation and Migration through the Transcription Factor E2F1 in Cervical Cancer Cells.
- Authors: Tian S, Zhang L, Li Y, Cao D, Quan S, Guo Y, Yang X, Yang T
- Issue date: 2021
- The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-β/Smad pathway in cervical cancer.
- Authors: Chen J, Deng Y, Ao L, Song Y, Xu Y, Wang CC, Choy KW, Tony Chung KH, Du Q, Sui Y, Yang T, Yang J, Li H, Zou C, Tang T
- Issue date: 2019 Sep 28
- The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1.
- Authors: Qiao L, Zhang Q, Zhang W, Chen JJ
- Issue date: 2018 Nov